Succeeding on the French Biosimilars Market

This new position paper, available by clicking on this link, provides key information to better understand the French biosimilars market.

In particular, you will find a presentation of:

• Recent measures implemented by health authorities to boost the use of biosimilars.
• The current market structure and dynamics and their likely evolution by 2023, in net value (exclusivity).
• The main characteristics of the two market segments (i.e. the hospital-only and the hybrid ones).
• The profitability of the leading players on each of these segments (exclusivity).

Smart Pharma Consulting has a unique expertise in the biosimilars market relying on "premium" strategic thinking and practical recommendations.

Feel free to contact us for more information.

Best regards,